1219 related articles for article (PubMed ID: 27373680)
1. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
[TBL] [Abstract][Full Text] [Related]
2. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
3. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
Oczypok EA; Perkins TN; Oury TD
Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
[TBL] [Abstract][Full Text] [Related]
4. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
5. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
6. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
Teissier T; Boulanger É
Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.
Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B
Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Biotechnol Appl Biochem; 2020 Mar; 67(2):265-272. PubMed ID: 31654427
[TBL] [Abstract][Full Text] [Related]
9. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y
Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171
[TBL] [Abstract][Full Text] [Related]
11. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
12. Activation of the receptor for advanced glycation end products and consequences on health.
Wautier MP; Guillausseau PJ; Wautier JL
Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
14. The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases.
Delrue C; Speeckaert R; Delanghe JR; Speeckaert MM
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769213
[TBL] [Abstract][Full Text] [Related]
15. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
16. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
17. RAGE and its ligands: from pathogenesis to therapeutics.
Jangde N; Ray R; Rai V
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
[TBL] [Abstract][Full Text] [Related]
18. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.
Antonelli A; Di Maggio S; Rejman J; Sanvito F; Rossi A; Catucci A; Gorzanelli A; Bragonzi A; Bianchi ME; Raucci A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):354-364. PubMed ID: 27913191
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
20. AGE/RAGE in diabetic kidney disease and ageing kidney.
Wu XQ; Zhang DD; Wang YN; Tan YQ; Yu XY; Zhao YY
Free Radic Biol Med; 2021 Aug; 171():260-271. PubMed ID: 34019934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
